Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
1150.0000 25.50 (2.27%)
NSE Aug 26, 2026 15:31 PM
Volume: 1.4M
 

1150.00
2.27%
Deven Choksey
Zydus Lifesciences is well positioned for sustained growth, supported by continued outperformance in India, accelerating international formulations and a gradual improvement in the US business mix.
Number of FII/FPI investors increased from 698 to 720 in Jun 2026 qtr.
More from Zydus Lifesciences Ltd.
Recommended